Table 2.

Ethnic differences in diarrheal side effects in respondents switching from BID SGCs to BID tablets

	BID Respondents (n = 332)	White (n = 136)	Black (n = 123)	Hispanic (n = 67)
Relative Risk (Tablets vs. SGCs)
Antidiarrheal use (more than "rarely use")	0.73*	0.72*	0.95	0.65
Diarrhea frequency 3+ per week	0.60*	0.68*	0.52*	0.39*
Respondent self-defined "severe" diarrhea	0.28*	0.47*	0.13*	0.17*
Proportion of respondents (Tablets vs. SGCs)
Respondent self-defined "severe" diarrhea	3.3% vs. 11.7%*	7% vs. 15%*	1% vs. 8%*	2% vs. 12%*

* p < 0.05